Recently, it has been reported that increased spondin-2 gene and protein expression was observed in ovarian cancer [10, 11], liver cancer [12, 13], prostate cancer [14, 15] and pancreatic cancer [16]. This evidence concerns the gene SPON2 and prostate cancer.